Arava (Ah-RAY-va, leflunomide), a new disease-modifying drug for rheumatoid arthritis
October 1998
Hoechst is now shipping Arava (Ah-RAY-va, leflunomide), a new disease-modifying drug for rheumatoid arthritis.
Arava relieves pain and swelling...and slows joint damage. It works by inhibiting the production of immune cells that attack the joints.
It's as effective as methotrexate or sulfasalazine.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote